Celgene Says Drug Buyers' Second Try For Cert. No Better
A proposed class of drug buyers accusing Celgene Corp. of creating a monopoly on two of its drugs shouldn't get a second crack at class certification, the biopharmaceutical company told a...To view the full article, register now.
Already a subscriber? Click here to view full article